Population-based versus practice-based recall for childhood immunizations: a randomized controlled comparative effectiveness trial
- PMID: 23237154
- PMCID: PMC3619016
- DOI: 10.2105/AJPH.2012.301035
Population-based versus practice-based recall for childhood immunizations: a randomized controlled comparative effectiveness trial
Abstract
Objectives: We compared the effectiveness and cost-effectiveness of population-based recall (Pop-recall) versus practice-based recall (PCP-recall) at increasing immunizations among preschool children.
Methods: This cluster-randomized trial involved children aged 19 to 35 months needing immunizations in 8 rural and 6 urban Colorado counties. In Pop-recall counties, recall was conducted centrally using the Colorado Immunization Information System (CIIS). In PCP-recall counties, practices were invited to attend webinar training using CIIS and offered financial support for mailings. The percentage of up-to-date (UTD) and vaccine documentation were compared 6 months after recall. A mixed-effects model assessed the association between intervention and whether a child became UTD.
Results: Ten of 195 practices (5%) implemented recall in PCP-recall counties. Among children needing immunizations, 18.7% became UTD in Pop-recall versus 12.8% in PCP-recall counties (P < .001); 31.8% had documented receipt of 1 or more vaccines in Pop-recall versus 22.6% in PCP-recall counties (P < .001). Relative risk estimates from multivariable modeling were 1.23 (95% confidence interval [CI] = 1.10, 1.37) for becoming UTD and 1.26 (95% CI = 1.15, 1.38) for receipt of any vaccine. Costs for Pop-recall versus PCP-recall were $215 versus $1981 per practice and $17 versus $62 per child brought UTD.
Conclusions: Population-based recall conducted centrally was more effective and cost-effective at increasing immunization rates in preschool children.
Trial registration: ClinicalTrials.gov NCT01296906.
Figures



Similar articles
-
Collaborative centralized reminder/recall notification to increase immunization rates among young children: a comparative effectiveness trial.JAMA Pediatr. 2015 Apr;169(4):365-73. doi: 10.1001/jamapediatrics.2014.3670. JAMA Pediatr. 2015. PMID: 25706340 Clinical Trial.
-
Centralized Reminder/Recall to Increase Immunization Rates in Young Children: How Much Bang for the Buck?Acad Pediatr. 2017 Apr;17(3):330-338. doi: 10.1016/j.acap.2016.11.016. Epub 2016 Nov 29. Acad Pediatr. 2017. PMID: 27913163 Clinical Trial.
-
Cost-effectiveness of childhood immunization reminder/recall systems in urban private practices.Pediatrics. 2000 Jul;106(1 Pt 2):177-83. Pediatrics. 2000. PMID: 10888689 Clinical Trial.
-
Factors related to immunization status among inner-city Latino and African-American preschoolers.Pediatrics. 1995 Aug;96(2 Pt 1):295-301. Pediatrics. 1995. PMID: 7630688
-
Effect of patient reminder/recall interventions on immunization rates: A review.JAMA. 2000 Oct 11;284(14):1820-7. doi: 10.1001/jama.284.14.1820. JAMA. 2000. PMID: 11025835 Review.
Cited by
-
A Celebration of the Life and Work of Caroline Breese Hall, MD.J Pediatric Infect Dis Soc. 2016 Mar;5(1):e1-4. doi: 10.1093/jpids/piu118. Epub 2014 Dec 8. J Pediatric Infect Dis Soc. 2016. PMID: 26908498 Free PMC article. No abstract available.
-
Costs of Interventions to Increase Vaccination Coverage Among Children in the United States: A Systematic Review.Acad Pediatr. 2021 May-Jun;21(4S):S67-S77. doi: 10.1016/j.acap.2020.11.015. Acad Pediatr. 2021. PMID: 33958096 Free PMC article.
-
Centralized Reminder/Recall to Increase Influenza Vaccination Rates: A Two-State Pragmatic Randomized Trial.Acad Pediatr. 2020 Apr;20(3):374-383. doi: 10.1016/j.acap.2019.10.015. Epub 2019 Nov 5. Acad Pediatr. 2020. PMID: 31698085 Free PMC article. Clinical Trial.
-
Parental Choice of Recall Method for HPV Vaccination: A Pragmatic Trial.Pediatrics. 2016 Mar;137(3):e20152857. doi: 10.1542/peds.2015-2857. Epub 2016 Feb 26. Pediatrics. 2016. PMID: 26921286 Free PMC article. Clinical Trial.
-
Systematic review of the costs for vaccinators to reach vaccination sites: Incremental costs of reaching hard-to-reach populations.Vaccine. 2021 Jul 30;39(33):4598-4610. doi: 10.1016/j.vaccine.2021.05.019. Epub 2021 Jul 6. Vaccine. 2021. PMID: 34238610 Free PMC article.
References
-
- Centers for Disease Control and Prevention Ten great public health achievements–United States, 1900-1999. MMWR Morb Mortal Wkly Rep. 1999;48(12):241–243 - PubMed
-
- Centers for Disease Control and Prevention Impact of vaccines universally recommended for children–United States, 1990-1998. MMWR Morb Mortal Wkly Rep. 1999;48(12):243–248 - PubMed
-
- McNabb SJ, Jajosky RA, Hall-Baker PAet al.Summary of notifiable diseases—United States, 2005. MMWR Morb Mortal Wkly Rep. 2007;54(53):1–92 - PubMed
-
- US Department of Health and Human Services, Office of Disease Prevention and Health Promotion Healthy People 2020. Available at: http://www.healthypeople.gov/2020/topicsobjectives2020. Accessed February 15, 2012 - PubMed
-
- Briss PA, Rodewald LE, Hinman ARet al.Reviews of evidence regarding interventions to improve vaccination coverage in children, adolescents, and adults. The Task Force on Community Preventive Services. Am J Prev Med. 2000;18(suppl):97–140 - PubMed
Publication types
MeSH terms
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical